In the US, Tazicef (ceftazidime systemic) is a member of the drug class third generation cephalosporins and is used to treat Bacteremia, Bladder Infection, Bone infection, Endocarditis, Endometritis, Febrile Neutropenia, Intraabdominal Infection, Joint Infection, Kidney Infections, Melioidosis, Meningitis, Nosocomial Pneumonia, Otitis Externa, Otitis Media, Pelvic Inflammatory Disease, Peritonitis, Pneumonia, Pneumonia with Cystic Fibrosis, Sepsis, Septicemia, Sinusitis, Skin and Structure Infection, Skin or Soft Tissue Infection and Urinary Tract Infection.
Ingredient matches for Tazicef
Ceftazidime is reported as an ingredient of Tazicef in the following countries:
- South Korea
- United States